Acute negative inotropic effects of homocysteine are mediated via the endothelium

[PDF] [Full Text] , November 1, 2005; 26 (21): 2215-2217. Eur. Heart J. M. de Lorgeril, P. Salen and P. Defaye Importance of nutrition in chronic heart failure patients [PDF] [Full Text] , July 1, 2006; 291 (1): H26-H28. Am J Physiol Heart Circ Physiol P. Rocic, B. Rezk and P. A. Lucchesi hope for ailing diabetic hearts? PPAR-{gamma} agonists decrease hyperhomcysteinemia and cardiac dysfunction: new [PDF] [Full Text] [Abstract] , October 1, 2006; 8 (6): 571-576. Eur J Heart Fail M. Herrmann, O. Taban-Shomal, U. Hubner, M. Bohm and W. Herrmann A review of homocysteine and heart failure [PDF] [Full Text] [Abstract] , January 15, 2007; 73 (2): 298-309. Cardiovasc Res S. von Haehling, W. Doehner and S. D Anker failure Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart [PDF] [Full Text] [Abstract] , January 16, 2007; 115 (2): 180-187. Circulation K. Nasir, M. Tsai, B. D. Rosen, V. Fernandes, D. A. Bluemke, A. R. Folsom and J. A.C. Lima The Multi-Ethnic Study of Atherosclerosis Elevated Homocysteine Is Associated With Reduced Regional Left Ventricular Function:

[1]  W. Lochner,et al.  The importance of the perfusion pressure in the coronary arteries for the contractility and the oxygen consumption of the heart , 2004, Pflüger's Archiv für die gesamte Physiologie des Menschen und der Tiere.

[2]  D. Levy,et al.  Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction , 2003 .

[3]  M. Hauer-Jensen,et al.  Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats. , 2003, American journal of physiology. Heart and circulatory physiology.

[4]  D. Brutsaert,et al.  Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. , 2003, Physiological reviews.

[5]  L. Fink,et al.  Hyperhomocysteinemia leads to adverse cardiac remodeling in hypertensive rats. , 2002, American journal of physiology. Heart and circulatory physiology.

[6]  S. Katz,et al.  Effect of Dexrazoxane on Homocysteine-Induced Endothelial Dysfunction in Normal Subjects , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[7]  M. Wajner,et al.  On the mechanism of the inhibition of Na+, K+-ATPase activity caused by homocysteine , 2002, International Journal of Developmental Neuroscience.

[8]  G. Chwatko,et al.  Determination of different species of homocysteine in human plasma by high-performance liquid chromatography with ultraviolet detection. , 2002, Journal of chromatography. A.

[9]  P. Tsao,et al.  Homocysteine Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine , 2001, Circulation.

[10]  J. Loscalzo,et al.  Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Z. Ungvari,et al.  Homocysteine Reduces Smooth Muscle [Ca2+]i and Constrictor Responses of Isolated Arterioles , 2001, Journal of cardiovascular pharmacology.

[12]  K. Patel,et al.  Inhibition of K+ Currents by Homocysteine in Rat Ventricular Myocytes , 2001, Journal of cardiovascular electrophysiology.

[13]  Ranz,et al.  DECREASED RATE OF CORONARY RESTENOSIS AFTER LOWERING OF PLASMA HOMOCYSTEINE LEVELS , 2001 .

[14]  J. Loscalzo,et al.  Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. , 2000, The Journal of clinical investigation.

[15]  G. Wright,et al.  Short-term exposure to homocysteine depresses rat aortic contractility by an endothelium-dependent mechanism. , 2000, Canadian journal of physiology and pharmacology.

[16]  K. Mccully.  Vascular Pathology of Hyperhomocysteinemia , 2000 .

[17]  Elga,et al.  PLASMA HOMOCYSTEINE LEVELS AND MORTALITY IN PATIENTS WITH CORONARY ARTERY DISEASE , 2000 .

[18]  S. Tyagi,et al.  Homocyst(e)ine impairs endocardial endothelial function. , 1999, Canadian journal of physiology and pharmacology.

[19]  S. Vollset,et al.  Total homocysteine and cardiovascular disease , 1999, Journal of internal medicine.

[20]  J. Blacher,et al.  Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease. , 1999, Journal of nephrology.

[21]  N. Westerhof,et al.  Perfusion-induced changes in cardiac contractility depend on capillary perfusion. , 1998, American journal of physiology. Heart and circulatory physiology.

[22]  J. Loscalzo,et al.  Homocyst(e)ine Decreases Bioavailable Nitric Oxide by a Mechanism Involving Glutathione Peroxidase* , 1997, The Journal of Biological Chemistry.

[23]  J. Loscalzo.  The oxidant stress of hyperhomocyst(e)inemia. , 1996, The Journal of clinical investigation.

[24]  P. Pratt,et al.  Simultaneous determination of nitrate and nitrite in biological samples by multichannel flow injection analysis. , 1995, Analytical biochemistry.

[25]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[26]  A. Sharkey,et al.  Cardiac endothelial cells modulate contractility of rat heart in response to oxygen tension and coronary flow. , 1993, Circulation research.

[27]  J. Rouleau,et al.  Effect of dysfunctional vascular endothelium on myocardial performance in isolated papillary muscles. , 1993, Circulation research.

[28]  J. Stamler,et al.  Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. , 1993, The Journal of clinical investigation.

[29]  E. Corey,et al.  Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro. , 1982, The Journal of pharmacology and experimental therapeutics.

[30]  N. Dhalla,et al.  Prostaglandin actions and interactions on isolated perfused rat hearts. , 1979, Canadian journal of physiology and pharmacology.

[31]  J. Papp,et al.  Cardiac actions of arachidonic acid. , 1976, Acta biologica et medica Germanica.

[32]  D. E. Gregg,et al.  Effect of Coronary Perfusion Pressure or Coronary Flow on Oxygen Usage of the Myocardium , 1963, Circulation research.